US 8124627
Biphenyl compounds useful as muscarinic receptor antagonists
granted A61PA61P1/04A61P1/12
Quick answer
US patent 8124627 (Biphenyl compounds useful as muscarinic receptor antagonists) held by Theravance, Inc. expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P1/04, A61P1/12, A61P11/00, A61P11/02